Nuevolution is a biotech company with the goal to deliver drugs of the future for the treatment of cancer and inflammatory diseases. Nuevolution has a patent-protected drug research platform to identify small-molecule drug candidates against cancer and inflammatory diseases.

The company was IPO:ed in Stockholm in 2015 and acquired by Amgen in 2019.